PMID: 2505216Jan 1, 1989Paper

Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa

Pediatric Pulmonology
I MacLuskyH Levison

Abstract

Twenty-seven patients with cystic fibrosis and endobronchial colonization with Pseudomonas aeruginosa were randomly assigned to inhale either 2 mL saline (12 patients) or 80 mg tobramycin solution (15 patients) 3 times daily. One control patient died; all others completed the study (mean duration 32 months). No significant differences were found between the two groups at enrollment. The treatment group showed no change, while the control group had a significant decline in both pulmonary function and clinical status over the study period. Individually, 11 of 12 patients in the control group showed deterioration, while 9 of 15 in the treatment group with susceptible P. aeruginosa at enrollment acquired resistant organisms. There was no evidence of significant nephro- or ototoxicity. Although inhaled tobramycin appeared to arrest the decline in pulmonary status, further work is required to identify patients most likely to respond.

References

Jan 1, 1987·The American Journal of Medicine·P CuginiD Scavo
Apr 1, 1974·The Journal of Pediatrics·P O AldersonR L Hill
Jun 11, 1983·Lancet·M A WallR Cohen
Jul 1, 1958·A.M.A. Journal of Diseases of Children·H SHWACHMAN, L L KULCZYCKI

❮ Previous
Next ❯

Citations

May 2, 2000·Pediatric Pulmonology·M Ramagopal, L C Lands
Jan 1, 1995·Pediatric Pulmonology. Supplement·A L Smith, B Ramsey
Nov 30, 2002·Advanced Drug Delivery Reviews·Lucila Garcia-Contreras, Anthony J Hickey
May 1, 1996·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·T Hagemann
Feb 13, 2001·International Journal of Antimicrobial Agents·F Ratjen
Jun 17, 1993·The New England Journal of Medicine·B W RamseyM A McBurnie
Jul 18, 1996·The New England Journal of Medicine·B W Ramsey
May 15, 2002·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Martin J LedsonMartin J Walshaw
Jun 27, 2006·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·G ReychlerG Liistro
Sep 27, 2007·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Allan L CoatesMartin Charron
Jan 15, 1998·Critical Care Medicine·G S Itokazu, R A Weinstein
Sep 30, 2003·Current Opinion in Otolaryngology & Head and Neck Surgery·Keith J Wahl, Alan Otsuji
Feb 1, 1991·Journal of Paediatrics and Child Health·P D Sly, P N Le Souëf
Feb 1, 1992·Journal of Paediatrics and Child Health·K Grimwood
Jan 15, 2011·Clinical Microbiology Reviews·Alan R HauserSusanna A McColley
Jun 1, 1993·Archives of Disease in Childhood·J M LittlewoodH Cunliffe
Mar 23, 1999·Archives of Disease in Childhood·S P Conway
Mar 23, 1999·Archives of Disease in Childhood·M Sood, I W Booth
Aug 10, 2000·American Journal of Respiratory and Critical Care Medicine·A F BarkerJ Quan
Sep 1, 2007·American Journal of Respiratory and Critical Care Medicine·Patrick A FlumeUNKNOWN Cystic Fibrosis Foundation, Pulmonary Therapies Committee
Nov 19, 2011·American Journal of Respiratory and Critical Care Medicine·Bruce C TrapnellUNKNOWN Phase 2 FTI Study Group
Jul 30, 2011·American Journal of Respiratory and Critical Care Medicine·Bradley S QuonChristopher H Goss
Jan 1, 1993·The Journal of Clinical Investigation·A Cantin, D E Woods
May 16, 2002·Pharmacotherapy·Michael J AsmusRichard C Ahrens
Jan 1, 2011·Medical Devices : Evidence and Research·Donald R Vandevanter, David E Geller
Jun 27, 2002·Paediatric Drugs·Isabelle Sermet-GaudelusGérard Lenoir
Mar 2, 2010·Infection·A Michalopoulos, E Papadakis
Jul 30, 2009·Expert Opinion on Drug Delivery·Daniela Traini, Paul M Young
Feb 20, 2016·Human Gene Therapy Methods·Heather S LoringTerence R Flotte
Jan 22, 2004·Chest·James R YankaskasDavid Rodman
May 27, 2010·Pharmacotherapy·Jennifer LeUNKNOWN Society of Infectious Diseases Pharmacists Aerosolized Antimicrobials Task Force
Feb 21, 2007·Expert Opinion on Pharmacotherapy·Jennifer K HagermanMichael E Klepser
Jun 23, 2006·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Patrick LebecqueVéronique Godding
Sep 27, 2013·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Luiz Vicente Ribeiro Ferreira da Silva FilhoJosé Dirceu Ribeiro
Aug 3, 2006·The Veterinary Clinics of North America. Equine Practice·Valerie A Brown, Pamela A Wilkins
Dec 4, 2008·Advances in Pediatrics·Reshma Amin, Felix Ratjen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.